Nitric oxide treatments as adjuncts to reperfusion in acute myocardial infarction: A systematic review of experimental and clinical studies

Basic Research in Cardiology

Volumn 111, Issue 2, 2016, Pages

  Bice, Justin S ^a   Jones, Bethan R ^a   Chamberlain, Georgia R ^a   Baxter, Gary F ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Ischaemia; Myocardial infarction; Nitric oxide; Reperfusion; Systematic review

Indexed keywords

CREATINE KINASE MB; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NITRATE; NITRIC OXIDE; NITROGEN DIOXIDE; NITROPRUSSIDE SODIUM; PEROXYNITRITE; PROTEIN KINASE B; SODIUM NITRATE;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; CARDIOVASCULAR PROCEDURE; CONCENTRATION RESPONSE; ENZYME RELEASE; HEART INFARCTION SIZE; HEART PROTECTION; HUMAN; META ANALYSIS; NITROSYLATION; NONHUMAN; REPERFUSION INJURY; REPERFUSION THERAPY; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ANIMAL; HEART MUSCLE REPERFUSION; MYOCARDIAL INFARCTION;

ANIMALS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NITRIC OXIDE;

EID: 85007125195     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-016-0540-y     Document Type: Review

References (66)

1. Higgins JPT, Green S (eds) (2011) Cochrane handbook for systematic reviews of interventions Version 5.1.0 [updated March 2011]. In: The Cochrane collaboration. Available via http://www.cochranehandbook.org
2. Baker JE, Su J, Fu X, Hsu A, Gross GJ, Tweddell JS, Hogg N (2007) Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels. J Mol Cell Cardiol 43:437–444. doi:10.1016/j.yjmcc. 2007.07.057
3. Bohn H, Brendel J, Martorana PA, Schonafinger K (1995) Cardiovascular actions of the furoxan CAS 1609, a novel nitric oxide donor. Br J Pharmacol 114:1605–1612. doi:10.1111/j.1476-5381. 1995.tb14946.x
4. Chouchani ET, Methner C, Nadtochiy SM, Logan A, Pell VR, Ding S, James AM, Cocheme HM, Reinhold J, Lilley KS, Partridge L, Fearnley IM, Robinson AJ, Hartley RC, Smith RAJ, Krieg T, Brookes PS, Murphy MP (2013) Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med 19:753–759. doi:10.1038/nm.3212
5. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim- Shapiro DB, Schechter AN, Cannon RO 3rd, Gladwin MT (2003) Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9:1498–1505. doi:10.1038/nm954
6. Curtis E, Hsu LL, Noguchi AC, Geary L, Shiva S (2012) Oxygen regulates tissue nitrite metabolism. Antioxid Redox Signal 17:951–961. doi:10.1089/ars.2011.4242
7. Dezfulian C, Raat N, Shiva S, Gladwin MT (2007) Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics. Cardiovasc Res 75:327–338. doi:10.1016/j.cardiores. 2007.05.001
8. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, Gladwin MT, Lefer DJ (2005) Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 115:1232–1240. doi:10.1172/JCI22493
9. Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R (2014) Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev 66:1142–1174. doi:10.1124/pr.113.008300
10. Ferdinandy P, Schulz R (2003) Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 138:532–543. doi:10.1038/sj.bjp.0705080
11. Giricz Z, Görbe A, Pipis J, Burley DS, Ferdinandy P, Baxter GF (2009) Hyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-30,50-cyclic monophosphate/ protein kinase G-dependent cardioprotection in rats. Br J Pharmacol 158:1495–1502. doi:10.1111/j.1476-5381.2009.00424.x
12. Gladwin MT, Schechter AN (2004) NO contest: nitrite versus S-nitroso-hemoglobin. Circ Res 94:851–855. doi:10.1161/01. RES.0000126697.64381.37
13. Gonon AT, Jung C, Katz A, Westerblad H, Shemyakin A, Sjoquist PO, Lundberg JO, Pernow J (2012) Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production. PLoS One 7:e42038. doi:10. 1371/journal.pone.0042038
14. Halestrap AP, Kerr PM, Javadov S, Woodfield KY (1998) Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1366:79–94
15. Harken AH, Simson MB, Haselgrove J, Wetstein L, Harden WR 3rd, Barlow CH (1981) Early ischemia after complete coronary ligation in the rabbit, dog, pig, and monkey. Am J Physiol 241:H202–H210
16. Hataishi R, Rodrigues AC, Neilan TG, Morgan JG, Buys E, Shiva S, Tambouret R, Jassal DS, Raher MJ, Furutani E, Ichinose F, Gladwin MT, Rosenzweig A, Zapol WM, Picard MH, Bloch KD, Scherrer-Crosbie M (2006) Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 291:H379–H384. doi:10.1152/ajpheart.01172.2005
17. Hendgen-Cotta UB, Merx MW, Shiva S, Schmitz J, Becher S, Klare JP, Steinhoff HJ, Goedecke A, Schrader J, Gladwin MT, Kelm M, Rassaf T (2008) Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemiareperfusion injury. Proc Natl Acad Sci USA 105:10256–10261. doi:10.1073/pnas.0801336105
18. Heusch G (2015) Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 116:674–699. doi:10.1161/circresaha.116.305348
19. Heusch G, Post H, Michel MC, Kelm M, Schulz R (2000) Endogenous nitric oxide and myocardial adaptation to ischemia. Circ Res 87:146–152. doi:10.1161/01.res.87.2.146
20. Heusch P, Nensa F, Heusch G (2015) Is MRI really the gold standard for the quantification of salvage from myocardial infarction? Circ Res 117:222–224. doi:10.1161/circresaha.117. 306929
21. Hildebrandt P, Torp-Pedersen C, Joen T, Iversen E, Jensen G, Jeppesen D, Melchior T, Schytten HJ, Ringsdal V, Jensen J et al (1992) Reduced infarct size in nonreperfused myocardial infarction by combined infusion of isosorbide dinitrate and streptokinase. Am Heart J 124:1139–1144
22. Hill M, Takano H, Tang X-L, Kodani E, Shirk G, Bolli R (2001) Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation 104:694–699. doi:10.1161/hc3201.092218
23. Hoshida S, Yamashita N, Igarashi J, Nishida M, Hori M, Kamada T, Kuzuya T, Tada M (1995) Nitric oxide synthase protects the heart against ischemia-reperfusion injury in rabbits. J Pharmacol Exp Ther 274:413–418
24. Ikeda U, Shimpo M, Ikeda M, Minota S, Shimada K (2001) Lipophilic statins augment inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. J Cardiovasc Pharmacol 38:69–77
25. Johnson G III, Tsao P, Lefer AM (1990) Synergism between superoxide-dismutase and sodium-nitrite in cardioprotection following ischemia and reperfusion. Am Heart J 119:530–537. doi:10.1016/S0002-8703(05)80275-3
26. Johnson G III, Tsao PS, Lefer AM (1991) Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 19:244–252
27. Johnson G III, Tsao PS, Mulloy D, Lefer AM (1990) Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther 252:35–41
28. Jones DA, Pellaton C, Velmurugan S, Rathod KS, Andiapen M, Antoniou S, van Eijl S, Webb AJ, Westwood MA, Parmar MK, Mathur A, Ahluwalia A (2015) Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction. Circ Res 116:437–447. doi:10.1161/CIRCRESAHA.116.305082
29. Lefer AM, Siegfried MR, Ma XL (1993) Protection of ischemiareperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interaction. J Cardiovasc Pharmacol 22(Suppl 7):S27–S33
30. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J (1993) Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs. Circulation 88:2337–2350
31. Lefer DJ, Nakanishi K, Vinten-Johansen J (1993) Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 22(Suppl 7):S34–S43
32. Liu X, Huang Y, Pokreisz P, Vermeersch P, Marsboom G, Swinnen M, Verbeken E, Santos J, Pellens M, Gillijns H, Van de Werf F, Bloch KD, Janssens S (2007) Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion. J Am Coll Cardiol 50:808–817. doi:10.1016/j.jacc.2007.04.069
33. Martin C, Schulz R, Post H, Boengler K, Kelm M, Kleinbongard P, Gres P, Skyschally A, Konietzka I, Heusch G (2007) Microdialysis- based analysis of interstitial NO in situ: NO synthaseindependent NO formation during myocardial ischemia. Cardiovasc Res 74:46–55. doi:10.1016/j.cardiores.2006.12.020
34. Maxwell MP, Hearse DJ, Yellon DM (1987) Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 21:737–746
35. Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB (1996) Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 271:40–47
36. Moher D, Liberati A, Tetzlaff J, Altman DG, The PG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. doi:10. 1371/journal.pmed.1000097
37. Morris JL, Zaman AG, Smyllie JH, Cowan JC (1995) Nitrates in myocardial infarction: influence on infarct size, reperfusion, and ventricular remodelling. Br Heart J 73:310–319
38. Nagasaka Y, Buys ES, Spagnolli E, Steinbicker AU, Hayton SR, Rauwerdink KM, Brouckaert P, Zapol WM, Bloch KD (2011) Soluble guanylate cyclase-a1 is required for the cardioprotective effects of inhaled nitric oxide. Am J Physiol Heart Circ Physiol. doi:10.1152/ajpheart.00948.2010
39. Nagasaka Y, Fernandez BO, Garcia-Saura MF, Petersen B, Ichinose F, Bloch KD, Feelisch M, Zapol WM (2008) Brief periods of nitric oxide inhalation protect against myocardial ischemia-reperfusion injury. Anesthesiology 109:675–682. doi:10.1097/ALN.0b013e318186316e
40. Neye N, Enigk F, Shiva S, Habazettl H, Plesnila N, Kuppe H, Gladwin MT, Kuebler WM (2012) Inhalation of NO during myocardial ischemia reduces infarct size and improves cardiac function. Intensive Care Med 38:1381–1391. doi:10.1007/ s00134-012-2605-1
41. Ng ESM, Jourd’heuil D, McCord JM, Hernandez D, Yasui M, Knight D, Kubes P (2004) Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ Res 94:559–565. doi:10.1161/01.res.0000117771.63140.d6
42. Nguyen TT, Stevens MV, Kohr M, Steenbergen C, Sack MN, Murphy E (2011) Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J Biol Chem 286:40184–40192. doi:10.1074/jbc. M111.243469
43. Nossuli TO, Hayward R, Jensen D, Scalia R, Lefer AM (1998) Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Am J Physiol 275:H509–H519
44. Nossuli TO, Hayward R, Scalia R, Lefer AM (1998) Cellular mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Faseb J 12:A1113–A1113
45. Nossuli TO, Hayward R, Scalia R, Lefer AM (1997) Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation 96:2317–2324. doi:10.1161/01.cir.96.7.2317
46. Núñez C, Víctor VM, Tur R, Alvarez-Barrientos A, Moncada S, Esplugues JV, D’Ocón P (2005) Discrepancies between nitroglycerin and NO-releasing drugs on mitochondrial oxygen consumption, vasoactivity, and the release of NO. Circ Res 97:1063–1069. doi:10.1161/01.res.0000190588.84680.34
47. Pabla R, Buda AJ, Flynn DM, Salzberg DB, Lefer DJ (1995) Intracoronary nitric-oxide improves postischemic coronary blood-flow and myocardial contractile function. Am J Physiol Heart Circ Physiol 269:H1113–H1121
48. Pechánová O, Varga ZV, Cebová M, Giricz Z, Pacher P, Ferdinandy P (2015) Cardiac NO signalling in the metabolic syndrome. Br J Pharmacol 172:1415–1433. doi:10.1111/bph. 12960
49. Penna C, Mancardi D, Rastaldo R, Pagliaro P (2009) Cardioprotection: a radical view. Free radicals in pre and postconditioning. Biochimica et Biophysica Acta Bioenerg 1787:781–793. doi:10.1016/j.bbabio.2009.02.008
50. Piper HM, Abdallah Y, Schafer C (2004) The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 61:365–371. doi:10.1016/j.cardiores.2003.12.012
51. Raphael J, Gozal Y, Navot N, Zuo Z (2010) Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling. J Cardiovasc Pharmacol 55:348–357. doi:10.1097/FJC.0b013e3181d26583
52. Rassaf T, Ferdinandy P, Schulz R (2014) Nitrite in organ protection. Br J Pharmacol 171:1–11. doi:10.1111/Bph.12291
53. Salloum FN, Takenoshita Y, Ockaili RA, Daoud VP, Chou E, Yoshida KI, Kukreja RC (2007) Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K-ATP channels when administered at reperfusion following ischemia in rabbits. J Mol Cell Cardiol 42:453–458. doi:10.1016/j.yjmcc.2006.10.015
54. Schönafinger K (1999) Heterocyclic NO prodrugs. Il Farmaco 54:316–320. doi:10.1016/S0014-827X(99)00031-2
55. Schwartz BG, Kloner RA (2012) Coronary no reflow. J Mol Cell Cardiol 52:873–882. doi:10.1016/j.yjmcc.2011.06.009
56. Shinbo T, Kokubo K, Sato Y, Hagiri S, Hataishi R, Hirose M, Kobayashi H (2013) Breathing nitric oxide plus hydrogen gas reduces ischemia-reperfusion injury and nitrotyrosine production in murine heart. Am J Physiol Heart Circ Physiol 305:H542–H550. doi:10.1152/ajpheart.00844.2012
57. Shiva S, Sack MN, Duranski M, Ringwood LA, Wang X, Raghavachari N, Macarthur P, Burwell L, Brookes PS, Lefer DJ, Gladwin MT (2006) Nitrite mediates both classical and long term preconditioning from ischemia/reperfusion injury at the mitochondrial level. Free Radic Biol Med 41:S62–S62. doi:10. 1084/jem.20070198
58. Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, Burwell L, Wang X, MacArthur PH, Shoja A, Raghavachari N, Calvert JW, Brookes PS, Lefer DJ, Gladwin MT (2007) Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 204:2089–2102. doi:10.1084/jem.20070198
59. Siddiqi N, Neil C, Bruce M, MacLennan G, Cotton S, Papadopoulou S, Feelisch M, Bunce N, Lim PO, Hildick-Smith D, Horowitz J, Madhani M, Boon N, Dawson D, Kaski JC, Frenneaux M, investigators N (2014) Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI). Eur Heart J 35:1255–1262. doi:10.1093/ eurheartj/ehu096
60. Siegfried MR, Erhardt J, Rider T, Ma XL, Lefer AM (1992) Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 260:668–675
61. Stamler JS (2008) Nitroglycerin-mediated S-nitrosylation of proteins: a field comes full cycle. Circ Res 103:557–559. doi:10. 1161/circresaha.108.184341
62. Stamler JS, Loscalzo J (1992) Capillary zone electrophoretic detection of biological thiols and their S-nitrosated derivatives. Anal Chem 64:779–785
63. Tratsiakovich Y, Gonon AT, Kiss A, Yang J, Bohm F, Tornvall P, Settergren M, Channon KM, Sjoquist PO, Pernow J (2013) Myocardial protection by co-administration of L-arginine and tetrahydrobiopterin during ischemia and reperfusion. Int J Cardiol 169:83–88. doi:10.1016/j.ijcard.2013.08.075
64. Tripathi Y, Hegde BM, Raghuveer CV (1997) Effect of superoxide dismutase and acidified sodium nitrite on infarct size following ischemia and reperfusion in dogs. Indian J Physiol Pharmacol 41:248–256
65. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KAA, Julian D, Lengyel M, Neumann F-J, Ruzyllo W, Thygesen C, Underwood SR, Vahanian A, Verheugt FWA, Wijns W (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 24:28–66. doi:10.1016/ s0195-668x(02)00618-8
66. Webb A, Bond R, McLean P, Uppal R, Benjamin N, Ahluwalia A (2004) Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci USA 101:13683–13688. doi:10.1073/pnas.0402927101